Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119229) titled 'A prospective, observational cohort study: comparing the efficacy, safety and treatment burden of Pemoxatide versus Erythropoietin in the treatment of anemia in maintenance hemodialysis patients' on Feb. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Anhui Medical University Affiliated Fuyang Hospital
Condition:
Renal Anemia
Intervention:
Pemoxatide Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Pemoxatide Group:20;Erythropoietin Group:20;
Countries of Recruitment:
China
To know more, visit https:...